| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.0097 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |